Self-Expanding Stents Market Report 2026

Self-Expanding Stents Market Overview

• Self-Expanding Stents market size has reached to $3.49 billion in 2025 • Expected to grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 4.9% • Growth Driver: Revolutionizing Cardiovascular Care The Rise Of Self-Expanding Stents • Market Trend: Innovative Stent Solutions Enhance Blood Flow And Reduce Complications In Vein Blockages • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Self-Expanding Stents Market?

Self-expanding stents are medical devices designed to open and maintain the patency (openness) of narrowed or blocked blood vessels or tubular structures within the body. These stents are made of flexible materials, often metal alloys such as nitinol, which have the property of self-expansion when deployed in the body. The purpose of self-expanding stents is to treat various medical conditions characterized by the narrowing or occlusion of blood vessels or other tubular structures. The main types of self-expanding stents are gastrointestinal self-expanding stents, carotid self-expanding stents, endovascular self-expandable stents, and others. Gastrointestinal self-expanding stents are medical devices used to treat narrowing or blockages in the digestive tract by expanding and providing support to the affected area. For applications such as fem-pop artery stents, iliac artery stents, carotid artery stents, biliary stents, and others used by end users include hospitals, ambulatory surgical centers, and others.

What Is The Self-Expanding Stents Market Growth Forecast?

The self-expanding stents market size is expected to see steady growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, expansion of peripheral artery disease management, growing focus on durable vascular implants, rising adoption of advanced stent technologies, increasing healthcare investments in interventional devices. Major trends in the forecast period include increasing adoption of nitinol-based stent designs, rising demand for minimally invasive vascular procedures, growing use of self-expanding stents in peripheral interventions, expansion of drug-compatible stent platforms, enhanced focus on long-term vessel patency.

Global Self-Expanding Stents Market Segmentation

1) By Product Type: Gastrointestinal Self-Expanding Stents, Carotid Self-Expanding Stents, Endovascular Self-Expandable Stents, Other Product Types 2) By Applications: Fem-Pop Artery Stents, Iliac Artery Stents, Carotid Artery Stents, Biliary Stents, Other Applications 3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Gastrointestinal Self-Expanding Stents: Esophageal Stents, Duodenal Stents, Colonic Stents 2) By Carotid Self-Expanding Stents: Proximal Protection Carotid Stents, Self-Expanding Carotid Stents 3) By Endovascular Self-Expandable Stents: Aortic Stents, Renal Artery Stents, Peripheral Artery Stents 4) By Other Product Types: Biliary Self-Expanding Stents, Urological Self-Expanding Stents

What Is The Driver Of The Self-Expanding Stents Market?

The growing prevalence of cardiovascular diseases is expected to propel the growth of the self-expanding stents market going forward. Cardiovascular illnesses are abnormalities of the heart and blood vessels. The growing cases of cardiovascular diseases is due to obesity, an aging population, and genetic predispositions. Self-expanding stents are useful in the therapy of cardiovascular disorders, as it provides effective and minimally invasive therapeutic alternatives for both urgent and long-term patient demands. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the self-expanding stents industry.

Key Players In The Global Self-Expanding Stents Market

Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Becton Dickinson And Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE And Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH

Global Self-Expanding Stents Market Trends and Insights

Major companies operating in the self-expanding stent market are focusing on developing innovative solutions, such as drug-eluting and bioresorbable stents, to improve vessel patency, reduce restenosis, and enhance patient outcomes. Drug-eluting stents slowly release medication to prevent artery re-narrowing, while bioresorbable stents are designed to dissolve over time after keeping the vessel open. For instance, in June 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Duo Venous Stent System in the U.S. to treat patients with blockages in their veins, specifically to address symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). These systems feature two types of self-expanding stents—Duo Hybrid and Duo Extend—designed to restore blood flow in blocked veins by providing flexibility, strength, and resistance to compression and vessel curvature. It aims to improve venous outflow in patients with chronic venous insufficiency while minimizing risks of stent fracture and corrosion.

What Are Latest Mergers And Acquisitions In The Self-Expanding Stents Market?

In January 2024, Olympus Corporation, a Japan-based technology company, acquired Taewoong Medical Co., Ltd. for an undisclosed amount. The acquisition aims to strengthen Olympus Corporation's GI endotherapy product portfolio and enhance its capabilities in providing comprehensive solutions for gastrointestinal (GI) treatments. Taewoong Medical Co. Ltd. is a South Korea-based medical device company that manufactures self-expanding metallic stents (SEMS) for various gastrointestinal applications.

Regional Outlook

North America was the largest region in the self-expanding stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Self-Expanding Stents Market?

The self-expanding stents market consists of sales of coronary self-expanding stents, peripheral self-expanding stents, and biliary self-expanding stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.